Dynamic bioinformatic assay revealed that plasma IGF-1 level is higher in day 1, but lower in day 3 in severe pneumonia-associated ARDS than that in severe pneumonia [153]. This evidence concerns the gene IGF1 and susceptibility to pneumonia measurement.